141-86-6 99%
| Price | Get Latest Price | ||||
| Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:1MT
- Time:2023-06-06
Product Details
- Product Name2,6-Diamino Pyridine
- CAS No.141-86-6
- EINECS No.205-507-2
- MFC5H7N3
- MW109.13
- InChIKeyVHNQIURBCCNWDN-UHFFFAOYSA-N
- AppearanceFlakes or Crystalline PowderBeige to dark brown-gray
- Water Solubility 9.9 g/100 mL (20 ºC)
- Melting point 117-122 °C (lit.)
- Boiling point 285 °C (lit.)
- storage temp. Store below +30°C.
- density 1.7110 (rough estimate)
Company Profile Introduction
Altrakem Pharma Lifesciences Pvt. Ltd. is a Hyderabad, India based company with a primary focus on offering chemistry services to pharmaceutical companies, biotech entities, academics, biomaterials, and catalysts industry. Altrakem offers custom synthesis, Pyridine Derivatives, Fine chemicals, Speciality chemicals Process Development for API Intermediates, Custom Synthesis of Pyridine Derivatives building blocks &Speciality chemicals , Large scale contract Manufacturing under GMP / Non GMP.
Supplier other products
Recommended supplier
-
VIP1年
- ARS ChemBlocks
- 141-86-6 2,6-Diaminopyridine 99%
- Inquiry
- 2024-10-23
-
VIP2年
- Gravitas Pharma Pvt Ltd
- 141-86-6
- Inquiry
- 2024-09-24
-
VIP2年
- VITAL SYNTHETICLABS PVT LTD
- 2,6-Diaminopyridine 141-86-6 98%
- Inquiry
- 2024-03-30
-
VIP0年
- VITAL SYNTHETICLABS PVT LTD
- 2,6-Diaminopyridine 141-86-6 98%
- Inquiry
- 2024-03-30
-
VIP1年
- Madin Life Sciences Pvt Ltd
- 141-86-6 2,6-Diaminopyridine 98%
- Inquiry
- 2024-03-12
-
VIP1年
- Jubilant Ingrevia
- 141-86-6 98%
- Inquiry
- 2024-02-08
-
VIP1年
- Ralington Pharma
- 141-86-6 2,6-Diaminopyridine 98%
- Inquiry
- 2024-02-05
-
VIP1年
- Valens Molecules
- 2,6-Diaminopyridine 141-86-6 98%
- Inquiry
- 2024-01-27
-
VIP1年
- Rivashaa Agrotech Biopharma Pvt. Ltd.
- 2,6-Diaminopyridine 98%
- Inquiry
- 2024-01-25
-
VIP1年
- Sintilla Medcoms Pvt Ltd
- 2,6-Diaminopyridine 98%
- Inquiry
- 2024-01-11
- Since:2023-05-18
- Address: Plot No. 5, Road No-15 CFC Area, IDA-Nacharam, Hyderabad, Telangana-500 076, India
INQUIRY